MedPath

Incyte Biosciences Distribution B.V.

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

7

EMA:4
NMPA:3

Drug Approvals

Tafasitamab for Injection

Product Name
明诺凯
Approval Number
国药准字SJ20250018
Approval Date
May 13, 2025
NMPA

Pemigatinib Tablets

Product Name
达伯坦
Approval Number
国药准字HJ20220027
Approval Date
Mar 29, 2022
NMPA

Pemigatinib Tablets

Product Name
达伯坦
Approval Number
国药准字HJ20220028
Approval Date
Mar 29, 2022
NMPA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.